SC Code § 44-53-190 (2021)
2021 South Carolina Code of Laws|Title 44 - Health|Chapter 53 - Poisons, Drugs And Other Controlled Substances|Section 44-53-190. Schedule I.

 (A) The controlled substances listed in this section are included in Schedule I.  (B) Any of the following opiates, including their isomers, esters, ethers, salts, and salts of isomers, esters, and ethers, unless specifically excepted, whenever the existence of such isomers, esters, ethers, and salts is possible within the specific chemical designation:  1. Acetylmethadol  2. Allylprodine  3. Alphacetylmethadol  4. Alphameprodine  5. Alphamethadol  6. Benzethidine  7. Betacetylmethadol  8. Betameprodine  9. Betamethadol  10. Betaprodine  11. Clonitazene  12. Dextromoramide  13. [Deleted]  14. Diampromide  15. Diethylthiambutene  16. Dimenoxadol  17. Dimepheptanol  18. Dimethylthiambutene  19. Dioxaphetyl butyrate  20. Dipipanone  21. Ethylmethylthiambutene  22. Etonitazene  23. Etoxeridine  24. Furethidine  25. Hydroxypethidine  26. Ketobemidone  27. Levomoramide  28. Levophenacylmorphan  29. Morpheridine  30. Noracymethadol  31. Norlevorphanol  32. Normethadone  33. Norpipanone  34. Phenadoxone  35. Phenampromide  36. Phenomorphan  37. Phenoperidine  38. Piritramide  39. Proheptazine  40. Properidine  41. Racemoramide  42. Trimeperidine  43. Propiram  44. Difenoxin  45. Alfentanyl  46. Tilidine  47. Alphamethylfentanyl (N-[1-(alpha-methyl-beta-phenyl) ethyl-4-piperidyl] propionanilide; 1-(1-methyl-2-phenylethyl-4-(N-pro-panilido) piperidine).  (C) Any of the following opium derivatives, their salts, isomers, and salts of isomers, unless specifically excepted, whenever the existence of such salts, isomers, and salts of isomers is possible within the specific chemical designation:  1. Acetorphine  2. Acetyldihydrocodeine  3. Benzylmorphine  4. Codeine methylbromide  5. Codeine-N-Oxide  6. Cyprenorphine  7. Desomorphine  8. Dihydromorphine  9. Etorphine  10. Heroin  11. Hydromorphinol  12. Methyldesorphine  13. Methylhydromorphine  14. Morphine methylbromide  15. Morphine methylsulfonate  16. Morphine-N-Oxide  17. Myrophine  18. Nicocodeine  19. Nicomorphine  20. Normorphine  21. Pholcodine  22. Thebacon  23. Drotebanol  (D) Any material, compound, mixture, or preparation which contains any quantity of the following hallucinogenic substances, their salts, isomers, and salts of isomers, unless specifically excepted, whenever the existence of such salts, isomers, and salts of isomers is possible within the specific chemical designation:  1. 3,4-methylenedioxy amphetamine  2. 5-methoxy-3,4-methylenedioxy amphetamine  3. 3,4-methylenedioxymethamphetamine (MDMA)  4. 3,4,5-trimethoxy amphetamine  5. Bufotenine  6. Diethyltryptamine (DET)  7. Dimethyltryptamine (DMT)  8. 4-methyl-2,5-dimethoxyamphetamine (STP)  9. Ibogaine  10. Lysergic acid diethylamide (LSD)  11. Marijuana  12. Mescaline  13. Peyote  14. N-ethyl-3-piperidyl benzilate  15. N-methyl-3-piperidyl benzilate  16. Psilocybin  17. Psilocyn  18. Tetrahydrocannabinol (THC)  19. 2,5-dimethoxyamphetamine  20. 4-bromo-2,5-dimethoxyamphetamine  21. 4-Methoxyamphetamine  22. Thiophene analog of phencyclidine  23. Parahexyl  24. Synthetic cannabinoids.-Any material, compound, mixture, or preparation that is not listed as a controlled substance in Schedule I through V, is not an FDA-approved drug, and contains any quantity of the following substances, their salts, isomers (whether optical, positional, or geometric), homologues, and salts of isomers and homologues, unless specifically excepted, whenever the existence of these salts, isomers, homologues, and salts of isomers and homologues is possible within the specific chemical designation:  a. Naphthoylindoles. Any compound containing a 3-(1-naphthoyl)indole structure with substitution at the nitrogen atom of the indole ring by an alkyl, haloalkyl, alkenyl, cycloalkylmethyl, cycloalkylethyl, 1-(N-methyl-2-piperidinyl)methyl, or 2-(4-morpholinyl)ethyl group, whether or not further substituted in the indole ring to any extent and whether or not substituted in the naphthyl ring to any extent. Including, but not limited to, JWH-015, JWH-018, JWH-019, JWH-073, JWH-081, JWH-122, JWH-200, JWH-210, JWH-398, AM-2201, WIN 55-212, AM-2201 (C1 analog), AM-1220.  b. Naphthylmethylindoles. Any compound containing a 1H-indol-3-yl-(1-naphthyl)methane structure with substitution at the nitrogen atom of the indole ring by an alkyl, haloalkyl, alkenyl, cycloalkylmethyl, cycloalkylethyl, 1-(N-methyl-2-piperidinyl)methyl, or 2-(4-morpholinyl)ethyl group, whether or not further substituted in the indole ring to any extent and whether or not substituted in the naphthyl ring to any extent.  c. Naphthoylpyrroles. Any compound containing a 3-(1-naphthoyl)pyrrole structure with substitution at the nitrogen atom of the pyrrole ring by an alkyl, haloalkyl, alkenyl, cycloalkylmethyl, cycloalkylethyl, 1-(N-methyl-2-piperidinyl)methyl, or 2-(4-morpholinyl)ethyl group, whether or not further substituted in the pyrrole ring to any extent and whether or not substituted in the naphthyl ring to any extent. Including, but not limited to, JWH-307, JWH-370, JWH-176.  d. Naphthylmethylindenes. Any compound containing a naphthylideneindene structure with substitution at the 3-position of the indene ring by an alkyl, haloalkyl, alkenyl, cycloalkylmethyl, cycloalkylethyl, 1-(N-methyl-2-piperidinyl)methyl, or 2-(4-morpholinyl)ethyl group, whether or not further substituted in the indene ring to any extent and whether or not substituted in the naphthyl ring to any extent.  e. Phenylacetylindoles. Any compound containing a 3-phenylacetylindole structure with substitution at the nitrogen atom of the indole ring by an alkyl, haloalkyl, alkenyl, cycloalkylmethyl, cycloalkylethyl, 1-(N-methyl-2-piperidinyl)methyl, or 2-(4-morpholinyl)ethyl group, whether or not further substituted in the indole ring to any extent and whether or not substituted in the phenyl ring to any extent. Including, but not limited to, SR-18, RCS-8, JWH-203, JWH-250, JWH-251.  f. Cyclohexylphenols. Any compound containing a 2-(3-hydroxycyclohexyl)phenol structure with substitution at the 5-position of the phenolic ring by an alkyl, haloalkyl, alkenyl, cycloalkylmethyl, cycloalkylethyl, 1-(N-methyl-2-piperidinyl)methyl, or 2-(4-morpholinyl)ethyl group, whether or not substituted in the cyclohexyl ring to any extent. Including, but not limited to, CP 47,497 (and homologues), cannabicyclohexanol, CP-55, 940.  g. Benzoylindoles. Any compound containing a 3-(benzoyl)indole structure with substitution at the nitrogen atom of the indole ring by an alkyl, haloalkyl, alkenyl, cycloalkylmethyl, cycloalkylethyl, 1-(N-methyl-2-piperidinyl)methyl, or 2-(4-morpholinyl)ethyl group, whether or not further substituted in the indole ring to any extent and whether or not substituted in the phenyl ring to any extent. Including, but not limited to, AM-694, Pravadoline (WIN 48,098), RCS-4, AM-630, AM-1241, AM-2233.  h. 2,3-Dihydro-5-methyl-3-(4-morpholinylmethyl)pyrrolo [1,2,3-de]-1, 4-benzoxazin-6-yl]-1-napthalenylmethanone (WIN 55,212-2).  i. 9-(hydroxymethyl)-6,6-dimethy l-3-(2-methyloctan-2-yl)-6a,7,10,10a-tetrahydrobenzo[c]chromen-1-ol 7370 (HU-210, HU-211).  j. Adamantoylindoles. Any compound containing a 3-(1-adamantoyl)indole structure with substitution at the nitrogen atom of the indole ring by a alkyl, haloalkyl, alkenyl, cycloalkylmethyl, cycloalkylethyl, 1-(N-methyl-2-piperidinyl)methyl or 2-(4-morpholinyl)ethyl group, whether or not further substituted in the indole ring to any extent and whether or not substituted in the adamantyl ring system to any extent.  (E) Depressants. Unless specifically excepted or unless listed in another schedule, any material, compound, mixture, or preparation which contains any quantity of the following substance having a depressant effect on the central nervous system, including its salts, isomers, and salts of isomers if possible within the specific chemical designation:  (1) Mecloqualone;  (2) Methaqualone; or  (3) Gamma Hydroxybutyric Acid.  (F) Stimulants. Unless specifically excepted or unless listed in another schedule, any material, compound, mixture, or preparation which contains any quantity of the following substances having a stimulant effect on the central nervous system, including its salts, isomers, and salts of isomers:  (1) Fenethylline;  (2) N-ethylamphetamine;  (3) Cathinone; or  (4) Substituted Cathinones.  Any compound (not being bupropion) structurally derived from 2-amino-1-phenyl-1-propanone by modification in any of the following ways:  (a) by substitution in the phenyl ring to any extent with alkyl, alkoxy, alkylenedioxy, haloalkyl or halide substituents, whether or not further substituted in the phenyl ring by one or more other univalent substituents;  (b) by substitution at the 3-position with an alkyl substituent;  (c) by substitution at the nitrogen atom with alkyl or dialkyl groups, benzyl or methoxybenzyl groups; or  (d) by inclusion of the nitrogen atom in a cyclic structure.  Including, but not limited to: Methylone, Mephedrone, 3,4-Methylenedioxypyrovalerone (MDPV), Butylone, Methedrone, 4-Methylethcathinone, Flephedrone, Pentylone, Pentedrone, Buphedrone.  HISTORY: 1962 Code Section 32-1510.31; 1971 (57) 800; 1974 (58) 2228; 1976 Act No. 672 Sections 2-4; 1978 Act No. 452 Section 1; 1981 Act No. 72, Section 1; 1982 Act No. 423 Sections 1, 2; 1985 Act No. 59 Sections 1-3; 2000 Act No. 355, Section 3; 2002 Act No. 267, Section 1, eff May 20, 2002; 2012 Act No. 140, Section 2, eff April 2, 2012.  Editor's Note  Section 44-53-160(B) authorizes the Department of Health and Environmental Control to add, delete, or reschedule a substance as a controlled substance when the General Assembly is not in session, and Section 44-53-160(C) requires the department to make such changes to conform to federal law. For a complete and accurate list of controlled substance schedules, please visit the department's website at http://www.scdhec.gov/Health/FHPF/DrugControlRegisterVerify/ControlledSubstanceSchedule/